Alesi Surgical Ltd

Alesi Surgical is a UK-based startup that is focused on developing and commercializing products to enhance the safety, efficiency, and outcomes of advanced surgical procedures. The company recently achieved a significant milestone in 2023, obtaining FDA clearance for its pioneering Ultravision2 smoke management solution. This innovative system integrates electrosurgery and class-leading surgical smoke control in a single laparoscopic device, marking a major advancement in the field of surgical technology. Founded in 2009, Alesi Surgical is a spin-out of the Welsh Institute for Minimal Access Therapy (WIMAT), a renowned surgical training center in the UK. The company's close ties to experienced surgeons, surgical trainers, and trainees provide it with a unique ability to identify procedural challenges and develop targeted solutions. Alesi Surgical is actively engaged in research and development of novel surgical technologies, guided by a 'needs-driven' approach. Its product development process is informed by rigorous testing and feedback from surgical trainers, ensuring the utility, usability, and seamless integration of its products into surgical practices. The Ultravision system is designed to deliver rapid and continuous resolution of surgical smoke. It is a compact, portable unit that seamlessly integrates with existing laparoscopic equipment and electrosurgical instruments. Alesi Surgical is open to collaborating with research-based companies or inventors to explore potential synergies in advancing surgical technology. Alesi Surgical's latest investment, a grant investment received on 19 December 2022, was provided by The European Innovation Council. The company operates primarily in the biotechnology and healthcare industries and is headquartered in the United Kingdom. With its FDA clearance and strong focus on innovation, Alesi Surgical is poised to make further strides in revolutionizing advanced surgical procedures.